297 related articles for article (PubMed ID: 11771737)
1. Developmental instability of the cerebellum and its relevance to Down syndrome.
Shapiro BL
J Neural Transm Suppl; 2001; (61):11-34. PubMed ID: 11771737
[TBL] [Abstract][Full Text] [Related]
2. Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse.
Baxter LL; Moran TH; Richtsmeier JT; Troncoso J; Reeves RH
Hum Mol Genet; 2000 Jan; 9(2):195-202. PubMed ID: 10607830
[TBL] [Abstract][Full Text] [Related]
3. Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes.
Olson LE; Roper RJ; Baxter LL; Carlson EJ; Epstein CJ; Reeves RH
Dev Dyn; 2004 Jul; 230(3):581-9. PubMed ID: 15188443
[TBL] [Abstract][Full Text] [Related]
4. Down syndrome gene dosage imbalance on cerebellum development.
Moldrich RX; Dauphinot L; Laffaire J; Rossier J; Potier MC
Prog Neurobiol; 2007 Jun; 82(2):87-94. PubMed ID: 17408845
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of trisomy on brain shape and volume in related aneuploid mouse models.
Aldridge K; Reeves RH; Olson LE; Richtsmeier JT
Am J Med Genet A; 2007 May; 143A(10):1060-70. PubMed ID: 17431903
[TBL] [Abstract][Full Text] [Related]
6. Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome.
Richtsmeier JT; Zumwalt A; Carlson EJ; Epstein CJ; Reeves RH
Am J Med Genet; 2002 Feb; 107(4):317-24. PubMed ID: 11840489
[TBL] [Abstract][Full Text] [Related]
7. Skeletal Deficits in Male and Female down Syndrome Model Mice Arise Independent of Normalized Dyrk1a Expression in Osteoblasts.
Thomas JR; Sloan K; Cave K; Wallace JM; Roper RJ
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828335
[TBL] [Abstract][Full Text] [Related]
8. App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome.
Cataldo AM; Petanceska S; Peterhoff CM; Terio NB; Epstein CJ; Villar A; Carlson EJ; Staufenbiel M; Nixon RA
J Neurosci; 2003 Jul; 23(17):6788-92. PubMed ID: 12890772
[TBL] [Abstract][Full Text] [Related]
9. Embryonic and not maternal trisomy causes developmental attenuation in the Ts65Dn mouse model for Down syndrome.
Blazek JD; Billingsley CN; Newbauer A; Roper RJ
Dev Dyn; 2010 Jun; 239(6):1645-53. PubMed ID: 20503361
[TBL] [Abstract][Full Text] [Related]
10. Mouse models of Down syndrome: gene content and consequences.
Gupta M; Dhanasekaran AR; Gardiner KJ
Mamm Genome; 2016 Dec; 27(11-12):538-555. PubMed ID: 27538963
[TBL] [Abstract][Full Text] [Related]
11. Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.
Kirsammer G; Jilani S; Liu H; Davis E; Gurbuxani S; Le Beau MM; Crispino JD
Blood; 2008 Jan; 111(2):767-75. PubMed ID: 17901249
[TBL] [Abstract][Full Text] [Related]
12. Sexually dimorphic DYRK1A overexpression on postnatal day 15 in the Ts65Dn mouse model of Down syndrome: Effects of pharmacological targeting on behavioral phenotypes.
Hawley LE; Prochaska F; Stringer M; Goodlett CR; Roper RJ
Pharmacol Biochem Behav; 2022 Jun; 217():173404. PubMed ID: 35576991
[TBL] [Abstract][Full Text] [Related]
13. Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice.
Richtsmeier JT; Baxter LL; Reeves RH
Dev Dyn; 2000 Feb; 217(2):137-45. PubMed ID: 10706138
[TBL] [Abstract][Full Text] [Related]
14. Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome.
Sago H; Carlson EJ; Smith DJ; Rubin EM; Crnic LS; Huang TT; Epstein CJ
Pediatr Res; 2000 Nov; 48(5):606-13. PubMed ID: 11044479
[TBL] [Abstract][Full Text] [Related]
15. Cerebellar alterations in a model of Down syndrome: The role of the Dyrk1A gene.
García-Cerro S; Vidal V; Lantigua S; Berciano MT; Lafarga M; Ramos-Cabrer P; Padro D; Rueda N; Martínez-Cué C
Neurobiol Dis; 2018 Feb; 110():206-217. PubMed ID: 29221819
[TBL] [Abstract][Full Text] [Related]
16. Overlapping trisomies for human chromosome 21 orthologs produce similar effects on skull and brain morphology of Dp(16)1Yey and Ts65Dn mice.
Starbuck JM; Dutka T; Ratliff TS; Reeves RH; Richtsmeier JT
Am J Med Genet A; 2014 Aug; 164A(8):1981-1990. PubMed ID: 24788405
[TBL] [Abstract][Full Text] [Related]
17. Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development.
Laffaire J; Rivals I; Dauphinot L; Pasteau F; Wehrle R; Larrat B; Vitalis T; Moldrich RX; Rossier J; Sinkus R; Herault Y; Dusart I; Potier MC
BMC Genomics; 2009 Mar; 10():138. PubMed ID: 19331679
[TBL] [Abstract][Full Text] [Related]
18. Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.
Olson LE; Roper RJ; Sengstaken CL; Peterson EA; Aquino V; Galdzicki Z; Siarey R; Pletnikov M; Moran TH; Reeves RH
Hum Mol Genet; 2007 Apr; 16(7):774-82. PubMed ID: 17339268
[TBL] [Abstract][Full Text] [Related]
19. Segmental trisomy of chromosome 17: a mouse model of human aneuploidy syndromes.
Vacík T; Ort M; Gregorová S; Strnad P; Blatny R; Conte N; Bradley A; Bures J; Forejt J
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4500-5. PubMed ID: 15755806
[TBL] [Abstract][Full Text] [Related]
20. Postnatal lethality and cardiac anomalies in the Ts65Dn Down syndrome mouse model.
Moore CS
Mamm Genome; 2006 Oct; 17(10):1005-12. PubMed ID: 17019652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
